Company patents
Baylor University
Baylor University's patent strategy is surprisingly concentrated, with over 60% of its portfolio in Display Drivers (64.3%), Optical Elements & Systems (62.2%), and Liquid Crystal & Optical Modulators (60.8%), all of which saw significant growth in 2025 (e.g., Liquid Crystal & Optical Modulators grew +40.9% YoY) before a sharp decline so far in 2026. Concurrently, Material & Chemical Analysis is an emerging focus, showing a +33.3% YoY growth in 2026, while its prior emphasis on pharmaceutical categories like Heterocyclic Compounds (Pharma) and Therapeutic Activity (Pharma) appears to be a shifting priority, with both declining by -100.0% YoY in 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
143 US filings (since 2023) · 11 categories · 10 themes
Algorithms and hardware implementations within display drivers or associated components to enhance visual quality, resolution, or color reproduction, including upscaling, dithering, and compensation for display artifacts like crosstalk.
Systems that combine light sources, waveguides, and display elements into unified products for backlighting, automotive applications, general lighting, or color-corrected displays.
Systems that employ imaging and image processing to automatically detect defects, verify states, or ensure quality control in manufactured goods, printed materials, or industrial processes.
Design and synthesis of acyclic or carbocyclic organic compounds that selectively modulate specific biological targets or pathways for the treatment of diseases.
Processes and methodologies for the efficient and scalable preparation of complex heterocyclic compounds and their precursors, including specific reaction conditions, purification techniques, and intermediate compounds.
Systems and devices for delivering gases, aerosols, or pressure support to the respiratory system, often including interfaces like masks and sophisticated control mechanisms for therapeutic effect or airway management.
Systems and methods that utilize optical fibers as sensing elements or for transmitting sensing signals, often for distributed monitoring of environmental conditions, phase changes, or integrating sensing with communication.
Delivery systems specifically engineered to administer advanced drug formulations (e.g., microparticles, biologics, extended-release systems) to achieve precise targeting, controlled release kinetics, or enhanced therapeutic efficacy within the body.
The design and manufacturing of integrated circuits that combine optical and electronic components, particularly for high-speed data communication between processors and memory.
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Patents
Showing 1-10 of 252